ImmunityBio (NASDAQ: IBRX) gains momentum as Piper Sandler upgrades to Overweight on Anktiva's success and strong growth prospects.
https://seekingalpha.com/news/4450542-immunitybio-upgraded-to-overweight-at-piper-sandler-on-anktiva-success
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.